Cargando…
Drug trapping in hERG K(+) channels: (not) a matter of drug size?
Inhibition of hERG K(+) channels by structurally diverse drugs prolongs the ventricular action potential and increases the risk of torsade de pointes arrhythmias and sudden cardiac death. The capture of drugs behind closed channel gates, so-called drug trapping, is suggested to harbor an increased p...
Autores principales: | Linder, Tobias, Bernsteiner, Harald, Saxena, Priyanka, Bauer, Florian, Erker, Thomas, Timin, Eugen, Hering, Steffen, Stary-Weinzinger, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292991/ https://www.ncbi.nlm.nih.gov/pubmed/28337337 http://dx.doi.org/10.1039/c5md00443h |
Ejemplares similares
-
New potential binding determinant for hERG channel inhibitors
por: Saxena, P., et al.
Publicado: (2016) -
In silico Analysis of Conformational Changes Induced by Mutation of Aromatic Binding Residues: Consequences for Drug Binding in the hERG K+ Channel
por: Knape, Kirsten, et al.
Publicado: (2011) -
Timothy Mutation Disrupts the Link between Activation and Inactivation in Ca(V)1.2 Protein
por: Depil, Katrin, et al.
Publicado: (2011) -
Timothy mutation affects tightly sealing point of Ca(V)1.2 activation gate
por: Depil, Katrin, et al.
Publicado: (2011) -
Binding of RPR260243 at the intracellular side of the hERG1 channel pore domain slows closure of the helix bundle crossing gate
por: Zangerl-Plessl, Eva-Maria, et al.
Publicado: (2023)